Bristol-Myers CEO talks new acquisitions: 'We’re writing the following bankruptcy of this corporate'
Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical large’s package of latest acquisitions in a Monday interview with CNBC’s Jim Cramer, and indicated the corporate is in a transformative level.”We’re writing the